Glaucoma Trial, Recruiting NCT07325552 Sponsor: Medical University of Bialystok Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT07325552
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Only one eye per participant will be included in the study
  • You have a cataract that your doctor considers significant enough to need treatment
  • You have glaucoma or higher-than-normal eye pressure that is currently being managed with one to four eye pressure-lowering medications, and you do not need major glaucoma surgery right now
  • The drainage angle inside your eye is open and healthy enough, as confirmed by a specific eye measurement called Schaffer grading (confirm with trial site)

Who may not be able to join:

  • You have had previous surgery for glaucoma, including any procedures that use heat or laser to reduce fluid production in the eye
  • You have had a specific laser eye treatment called Selective Laser Trabeculoplasty (SLT) within the last 90 days before the planned surgery
  • You have certain other serious eye conditions, such as a wet form of age-related macular degeneration, advanced diabetic eye disease, a significant inherited cornea condition, or any other eye disease that affects your eye pressure or vision (confirm with trial site)
  • You are unable to give written consent or take part fully due to another health condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +48600471666

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medical University of Bialystok
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
1 January 2027

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Change in the number of intraocular pressure lowering medications compared to baseline; Intraocular pressure measured by Goldmann applanation tonometry (GAT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov